SPECTRUM
  • Home
  • People
  • Partners
  • Resources
    • Publications
    • Video & Media
    • Articles
    • Projects
  • News and Events
  • Other Consortia
    • Home
    • SPARK
    • PRISM2

On this page

  • Related Projects
  • Related Publications
Headshot of Doctor Michael Lydeamore

Dr Michael Lydeamore

Email GitHub @MikeLydeamore More

Lecturer, Business Analytics

Department of Econometrics and Business Statistics, Monash University

Dr Lydeamore is an infectious disease modeller. His current research focuses on the dynamics of COVID-19, and quantifying the spread an designing control strategies for the spread of antimicrobial resistance in Victorian hospitals, at Monash University and The Alfred Central Clinical School. He acquired a PhD from The University of Melbourne in 2019 focusing on modelling the spread and control of skin infections. He has previously modelled antiviral allocation schemes in an influenza pandemic.

Related Projects

  • Modelling Report for National Cabinet

Related Publications

  • Zachreson, C., Shearer, F.M., Price, D.J., Lydeamore, M.J., McVernon, J., McCaw, J. and Geard, N., 2022. COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2. Science Advances, 8(14), p.eabm3624.
  • Doherty Institute, 2021. Doherty Modelling – Final report to National Cabinet, 5 November. Available at https://www.doherty.edu.au/our-work/institute-themes/viral-infectious-diseases/covid-19/covid-19-modelling/modelling (Accessed 24 April 2023).
  • Doherty Institute, 2021. Doherty Modelling – Final report to National Cabinet, 5 November. Available at https://www.doherty.edu.au/our-work/institute-themes/viral-infectious-diseases/covid-19/covid-19-modelling/modelling (Accessed 24 April 2023).
For more information or to report issues, please contact the consortia project inbox.
© May 2023 SPECTRUM
Cookie Preferences
Supporting Participatory Evidence generation to Control Transmissible diseases in our Region Using Modelling (SPECTRUM)
A Centre of Research Excellence (CRE) funded by the National Health and Medical Research Council (NHMRC).